« Back
Home /
Elotuzumab (anti-SLAMF7)

Elotuzumab (anti-SLAMF7)

Item no.	A2034-1mg
Manufacturer	Selleckchem
CASRN	915296-00-3
Amount	1 mg
Quantity options	1 mg 1 mg x 25 1 mg x 5
Category	Antibodies Primary Antibodies
Type	Antibody
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	BMS-901608,PDL063, HuLuc63
Available
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Information	Elotuzumab (anti-SLAMF7, BMS-901608, PDL063, HuLuc63) is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell–mediated antibody-dependent cellular cytotoxicity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A2034-1mg-datasheet.pdf

A2034-1mg-safety-datasheet.pdf